Novo terminates agreement with Hims & Hers to sell weight-loss drug
HQ Team June 23, 2025: Danish drugmaker Novo Nordisk will terminate its agreement with a US-based telehealth company, Hims & Hers Health Inc.,.
Drugs
Health
Medical